1. Introduction {#sec1-medicines-04-00051}
===============

Myrtaceae Juss. comprises 142 genera and about 5500 species of trees and shrubs, distributed in the tropical and subtropical regions of the world, with centers of diversity in Tropical America and Oceania, and a few species in Africa \[[@B1-medicines-04-00051]\]. In Brazil, it is one of the most diverse and is mainly represented by fruit trees. Twenty-three genera and about 1000 species were found and all belonged to the Myrtoideae subfamily and Myrteae tribe \[[@B2-medicines-04-00051],[@B3-medicines-04-00051]\]. *Eugenia* L. is one of the largest genera within Myrtaceae and 388 species are native in Brazil \[[@B3-medicines-04-00051]\]. *Eugenia egensis* DC., common name "cambuí" (syn. *E. egensis* var. *grandifolia* O. Berg, *E. erythrocarpa* Barb. Rodr., *E. parodiana* Morong, *E. perforata* O. Berg, *E. pothaplosantha* Barb. Rodr., *E. sphaerosperma* DC., *E. tenuiramis* Miq.), *Eugenia flavescens* DC., common name araçá-da-mata" (syn. *E. flavescens* var. *guianensis* Sagot), *Eugenia patrisii* Vahl, known as "ubaia-rubí" (syn. *E. berlynensis* O. Berg, *E. inocarpa* DC., *E. parkeriana* DC., *E. tefeensis* O. Berg, *E. vellozii* O. Berg., *stenocalyx patrisii* (Vahl) O. Berg), and *Eugenia polystachya* Rich. (syn. *E. forsteri* O. Berg, *E. schlechtendaliana* O. Berg) \[[@B4-medicines-04-00051]\] are shrubs or small trees of 2--5 m, with a wide occurrence in the Brazilian Amazon.

The Myrtaceae family is known for the high terpene concentration of the foliage and the considerable qualitative and quantitative variation in foliar terpenes at taxonomic, population, and individual levels \[[@B5-medicines-04-00051],[@B6-medicines-04-00051]\]. Many *Eugenia* species are appreciated for their edible fruits, such as *E. uniflora* L. (pitanga), *E. involucrata* DC. (cereja-do-mato), *E. jambolana* Lam. (jamelão), *E. pyriformis* Cambess. (uvaia), and *E. dysenterica* DC. (cagaita). Beyond the volatiles of the fruits, these species also accumulate essential oils in their leaves \[[@B7-medicines-04-00051],[@B8-medicines-04-00051],[@B9-medicines-04-00051],[@B10-medicines-04-00051],[@B11-medicines-04-00051]\]. Sesquiterpene hydrocarbons and oxygenated sesquiterpenes predominate in the essential oils of *Eugenia* and they are from the germacrane, caryophylane, and guaiane types \[[@B12-medicines-04-00051],[@B13-medicines-04-00051]\].

Essential oils of *Eugenia* have significant biological activities, such as anticonvulsant \[[@B14-medicines-04-00051]\], antibacterial \[[@B15-medicines-04-00051]\], antifungal \[[@B16-medicines-04-00051]\], antiparasitic \[[@B17-medicines-04-00051]\], and insecticidal \[[@B18-medicines-04-00051]\] activities. Additionally, some *Eugenia* oils have been reported as antioxidant and cytotoxic. The oil of *Eugenia caryophyllata* (clove) (syn. *Syzygium aromaticum* (L.) Merril & Perry) is rich in eugenol and is a powerful natural antioxidant, with different mechanisms of action, such as radical scavenging, metals chelation, and the inhibition of lipid peroxidation \[[@B19-medicines-04-00051]\]. Furthermore, clove oil showed cytotoxic activity and the induction of apoptosis in human promyelocytic leukemia cells (HL-60) \[[@B20-medicines-04-00051]\].

The aim of the present study was to analyze the composition of the oils of *Eugenia egensis*, *E. flavescens*, *E. patrisii*, and *E. polystachya*, and evaluate their cytotoxic and antioxidant properties.

2. Materials and Methods {#sec2-medicines-04-00051}
========================

2.1. Plant Material {#sec2dot1-medicines-04-00051}
-------------------

Botanical material (aerial parts, 500 g each plant) was collected in three municipalities located in the Southeast Pará state, Brazil, during the rainy season (January 2011). *Eugenia egensis* DC. (MG 181220) was collected in the city of Marabá. *Eugenia flavescens* DC. (MG 200127) and *E. polystachya* Rich. (MG191868) were sampled in the Carajás National Forest, in the town of Parauapebas. *Eugenia patrisii* Vahl. (MG 200132) was collected in the city of São Geraldo do Araguaia. *Eugenia* species vouchers were deposited in the Herbarium of Emilio Goeldi Museum (MG), the city of Belém, Pará state, Brazil.

2.2. Plant Processing and Extraction of the Essentials Oils {#sec2dot2-medicines-04-00051}
-----------------------------------------------------------

Aerial parts (leaves and thin stems) of the plants were air-dried, grinded, and submitted to hydrodistillation using Clevenger-type apparatus (100 g, 3 h). The oils were dried over anhydrous sodium sulfate, and their percentage contents were calculated by the plant dry weight. The moisture contents of the samples were computed after phase separation using a Dean--Stark trap (5 g, 60 min) and toluene as the solvent phase.

2.3. Oil Composition Analysis {#sec2dot3-medicines-04-00051}
-----------------------------

Analyses of the oils were carried out on a GC-MS Thermo-Electron model Focus DSQ II (Thermo Fisher Scientific, Waltham, MA, USA), under the following conditions: DB-5ms (30 m × 0.25 mm; 0.25 mm film thickness) fused-silica capillary column (Agilent J&W GC Columns, Santa Clara, CA, USA); programmed temperature, 60--240 °C (3 °C/min); injector temperature, 250 °C; carrier gas, helium, adjusted to a linear velocity of 32 cm/s (measured at 100 °C); injection type, split (1.0 μL), from 1:1000 hexane solution; split flow was adjusted to yield a 20:1 ratio; septum sweep was a constant 10 mL/min; EIMS, electron energy, 70 eV; temperature of the ion source and connection parts, 200 °C. The quantitative data regarding the volatile constituents were obtained by peak area normalization using a FOCUS GC/FID (Thermo Fisher Scientific, Waltham, MA, USA) operated under similar conditions for the GC--MS, except the carrier gas, which was nitrogen. The retention index was calculated for all the volatile constituents using a homologous series of *n*-alkanes (C~8~-C~32~, Sigma--Aldrich, St. Louis, MO, USA), according to Van den Dool and Kratz (1963) \[[@B21-medicines-04-00051]\].

2.4. Antioxidant Assay {#sec2dot4-medicines-04-00051}
----------------------

The antioxidant activity of the *Eugenia* oils was determined by the DPPH radical scavenging assay. DPPH is a stable dark violet free radical with a maximum absorption at 517 nm, which is reduced in the presence of antioxidants. Each sample (5 µL) was mixed with Tris-HCl buffer (100 mM, 900 µL, pH 7.4), ethanol (40 µL), and Tween 20 solution (0.5%, 50 µL, *w*/*w*), and was then added to DPPH (0.5 mM, 1 mL) in ethanol. The standard curves were prepared using Trolox and BHA (1.0 to 8.0 μg/mL), which are standards of hydrosoluble and liposoluble antioxidants, respectively. The results were expressed as milligrams of Trolox (mgTE/mL) and BHA (mg BHAE/mL) equivalents per milliliter of the sample \[[@B22-medicines-04-00051]\].

2.5. Cytotoxicity Assay (Against Cancer Cell Lines) {#sec2dot5-medicines-04-00051}
---------------------------------------------------

The MTT colorimetric assay was used to measure the cell metabolic activity \[[@B23-medicines-04-00051]\]. The oils (0.2 to 25 μg/mL) were tested for cytotoxic activity against three cancer cell lines: HCT-116 (colon), SKMEL19 (melanoma), AGP-01 (gastric). All cell lines were maintained in DMEM (Dulbecco's Modified Eagle Medium) medium supplemented with fetal bovine serum (10%), glutamine (2 mM), penicillin (100 U/mL), streptomycin (100 µg/mL) at 37 °C with 5% CO~2~. Each oil was dissolved in DMSO to obtain a concentration of 10 mg/mL. The final concentration of DMSO in the culture medium was kept constant, below 0.1% (*v*/*v*). Essential oils (25 μg) were incubated with the cells for 72 h. The negative control received the same amount of DMSO (0.001% in the highest concentration). The cell viability was determined by reduction of the yellow dye 3-(4,5-dimethyl-2-thiazol)-2,5-diphenyl-2*H*-tetrazolium bromide (MTT) to a blue formazan product. Doxorubicin and eugenol were the positive controls.

2.6. Cell Membrane Disruption {#sec2dot6-medicines-04-00051}
-----------------------------

The potential of the cell membrane lyses was evaluated by the release of the hemoglobin in the medium. The test was performed in 96-well plates using mouse hemoglobin suspension (2%) in NaCl solution (0.85%), containing CaCl~2~ (10 mM). The oils, diluted as mentioned above, were tested at 200 μg/mL. After incubation at room temperature for 1 h, followed by centrifugation, the supernatant was removed, and the liberated hemoglobin was measured spectrophotometrically at 540 nm. DMSO was used as the negative control and Triton X-100 (1%) was employed as the positive control \[[@B24-medicines-04-00051]\].

2.7. Statistical Analysis {#sec2dot7-medicines-04-00051}
-------------------------

Samples were assayed in triplicate, and the results are shown as means ± standard deviation. Analysis of variance was conducted, and the differences between variables were tested for significance by a Tukey test. Differences at *p* \< 0.05 were considered statistically significant. The *IC*~50~'s values were calculated by nonlinear regression using the GraphPad program (version 5.0, Intuitive Software for Science, San Diego, CA, USA).

3. Results and Discussion {#sec3-medicines-04-00051}
=========================

3.1. Essential Oil Composition {#sec3dot1-medicines-04-00051}
------------------------------

The dried leaves and fine stems (aerial parts) of *Eugenia egensis*, *E. flavescens*, *E. patrisii*, and *E. polystachya* provided oil yields of 2.5%, 1.0%, 0.7%, and 1.0%, respectively. Individual components were identified by comparison of both mass spectrum and GC retention data with authentic compounds, previously analyzed and stored in the data system. Furthermore, they were identified with the aid of commercial libraries containing the retention indices and mass spectra of volatile compounds, commonly found in essential oils \[[@B25-medicines-04-00051],[@B26-medicines-04-00051]\]. One hundred volatile compounds were identified, corresponding to an average of 93% of the total composition of the oils ([Table 1](#medicines-04-00051-t001){ref-type="table"}). Sesquiterpenes were the most highly represented class, as many hydrocarbons and oxygenated constituents.

The principal constituents (above 5%) of *E. egensis* oil were 5-hydroxy-*cis*-calemenene (35.8%), β-caryophyllene (8.9%), *trans*-cadina-1,4-diene (6.3%), *trans*-calamenene (6.1%), *trans*-muurola-3,5-diene (5.9%), and ledol (5.0%). These sesquiterpenes were grouped in accordance with the following biosynthetical pathways: cadinane, muurolane, and caryophyllane. *Eugenia polystachya* oil was dominated by germacrene D (18.4%), ishwarane (15.7%), 7-*epi*-α-selinene (7.5%), and bicyclogermacrene (5.1%). Therefore, sesquiterpenes presented the germacrane and selinane structural-types. To our knowledge, it is the first study on the composition of the *E. egensis* and *E. polystachya* oils, and the first report on the occurrence of 5-hydroxy-cis-calemenene as a significant constituent in *Eugenia* essential oils. Other sesquiterpenes with a germacrane skeleton have been reported in *E. protenta* \[[@B27-medicines-04-00051]\] and *E. uniflora* \[[@B28-medicines-04-00051]\].

*Eugenia flavescens* oil is rich in (*E*)-γ-bisabolene (35.0%), β-bisabolene (34.7%), and (*E*)-iso-γ-bisabolene (5.1%), comprising about 75.0% of the total oil composition. A previous study reported the occurrence of germacrene D and bicyclogermacrene in the oil of a specimen of *E. flavescens* collected in the city of Maracanã, Pará State, Brazil \[[@B29-medicines-04-00051]\]. A notable occurrence of the bisabolane skeleton was described in other Myrtaceae species. α-Bisabolene occurs in the oils of *Myrcia splendens* \[[@B13-medicines-04-00051]\], *M. fallax* and *M. glabra* \[[@B30-medicines-04-00051]\], *M. obtecta* \[[@B31-medicines-04-00051]\], *M. laruotteana* \[[@B32-medicines-04-00051]\], and *M. bracteata* \[[@B33-medicines-04-00051]\]. The oxygenated sesquiterpenes (2*E*,6*E*)-farnesol (34.5%), (2*E*,6*Z*)-farnesol (23.2%), and the mixture of caryophylla-4(12),8(13)-dien-5α-ol and caryophylla-4(12),8(13)-dien-5β-ol (15.6%) were the main constituents of the oil of *Eugenia patrissii*. Therefore, sesquiterpene compounds belong to the caryophyllane and acyclic groups. Another sample of *E. flavescens*, collected in the city of Maracanã, Pará State, Brazil, different to the sample studied in this paper, showed the hydrocarbon sesquiterpenes trans-cadina-1,4-diene, trans-muurola-3,5-diene, and β-caryophyllene, as the primary components \[[@B29-medicines-04-00051]\].

The difference found in the main constituents of the oils of *E. flavescens* and *E. patrissii*, when comparing them separately with the previously described oils \[[@B29-medicines-04-00051]\], is due to the presence of two distinct chemotypes, whose specimens were sampled at different collection sites; the first in a secondary forest area in the northeast of Pará and the second in an area of savanna in the south of Pará, Brazil, with a very diverse soil and climate environment, and a distance between them of about 1000 km.

3.2. Antioxidant Activity {#sec3dot2-medicines-04-00051}
-------------------------

The radical scavenging activity using the DPPH radical (2,2-diphenyl-1-picrylhydrazyl) was tested with the different *Eugenia* oils, and the absorbance at 517 nm was observed. Regarding percentage values, the inhibiting activity (over 120 min) was calculated in the following order: *E. egensis* (79.6 ± 4.3%), *E. flavescens* (45.1 ± 2.5%), *E. patrisii* (40.9 ± 4.6%), and *E. polystachya* (11.5 ± 1.3 %). The antioxidant activity was expressed in comparison with the Trolox and BHA standards ([Figure 1](#medicines-04-00051-f001){ref-type="fig"}).

The highest activity observed for the *E. egensis* oil (TEAC = 216.5 ± 11.6 mg TE/mL and 177.6 ± 9.8 mg BHAE/mL) could be attributed to the oxygenated sesquiterpene 5-hydroxy-*cis*-calamenene. The presence of a phenolic ring in the structure of 5-hydroxy-*cis*-calamenene enhances the antioxidant activity due to its ability for scavenging free radicals, the donation of hydrogen atoms or electrons, or chelation with metal cations \[[@B34-medicines-04-00051]\]. The oil of *Croton cajucara* Benth. that contains 33.0% of the isomer 7-hydroxy-calamenene, showed significant antioxidant activity in the DDPH assay and its *IC*~50~ value was 35.6 µg/mL, only four times less active than rutin (*IC*~50~ 9.3 µg/mL) \[[@B35-medicines-04-00051]\]. Additionally, it was reported that the isomer 8-hydroxy-calamenene could attenuate the retinal damage significantly, a common risk factor for glaucoma disease caused by oxidative stress, exhibiting neuroprotective effects when tested in vitro and in vivo \[[@B36-medicines-04-00051]\].

*Eugenia flavescens* (122.6 ± 6.8 mg TE/mL and 100.6 ± 5.4 mg BHAE/mL) and *E. patrisii* (111.2 ± 12.4 mg TE/mL and 91.3 ± 10.1 m BHAE/mL) oils showed moderate antioxidant activity. The main constituents of these two oils are sesquiterpene hydrocarbons with bisabolane and farnesane type structures, respectively (see [Table 1](#medicines-04-00051-t001){ref-type="table"}). The oil of *Psammogeton canescens* Vatke, rich in β-bisabolene (33.4%), showing significant antioxidant activity in the DPPH assay, was previously reported and strengthens our results \[[@B37-medicines-04-00051]\]. On the other hand, to the present date, no information has been reported on the antioxidant activity of the farnesol isomers.

3.3. Cytotoxic Activity {#sec3dot3-medicines-04-00051}
-----------------------

Among many valuable plant products, the essential oils are used in complementary medical treatment strategies. The action of essential oils and their constituents has been studied for a variety of cancer types \[[@B38-medicines-04-00051]\]. In the present study, the antiproliferative effect of different *Eugenia* oils was tested against three human cancer cell lines (AGP-01, HCT-116, and SKMEL-19) and one normal human fibroblast cell line (MRC-5), using the MTT assay. The *IC*~50~ values were determined after 72 h exposure, as shown in [Table 2](#medicines-04-00051-t002){ref-type="table"}. *Eugenia flavescens*, *E. patrisii*, and *E. polystachya* oils presented cytotoxicity against the HCT-116 colon cancer cell line, except for the oil of *E. egensis*, which did not display cytotoxicity against any of the cells until the concentration of 25 µg/mL. The oil of *E. polystachya* was the most active, with an *IC*~50~ value of 10.3 µg/mL. Germacrene D was the main constituent of this oil (18.4%) and, previously, it was identified with a significant percentage in the oils of *Guatteria diospyroides*, *G. oliviformis*, and *Unonopsis costaricensis*. These Annonaceae oils showed remarkable cytotoxic activities against MDA-MB-231 cells (human breast tumor) \[[@B39-medicines-04-00051]\]. The germacrane group was also highlighted in the study of the essential oil of *Porcelia macrocarpa*, another Annonaceae species. A mixture of germacrene D and bicyclogermacrene isolated from its oil showed significant cytotoxic potential against HL-60 cells (human leukemia) \[[@B40-medicines-04-00051]\]. As mentioned before, the oil of *Eugenia caryophyllata* (clove) exhibits strong cytotoxic activity in HL-60 cells \[[@B20-medicines-04-00051]\], as well as being active against colon and melanoma cancer cells \[[@B41-medicines-04-00051],[@B42-medicines-04-00051]\]. Thus, the results in [Table 2](#medicines-04-00051-t002){ref-type="table"} were compared to eugenol, the major constituent of clove oil. Interestingly, the oil of *E. polystachya* exhibits no activity against the normal MRC-5 fibroblast cell line, whereas the other two oils from *E. flavescens* and *E. patrisii* display the same range of cytotoxicity on HCT-116 cancer cells and in MCR-5 normal cells, what makes them suitable for further investigation. To our knowledge, this is the first time that the cytotoxic activity of these oils has been reported. All tested oils did not display lytic activity against red blood cells (see [Table 2](#medicines-04-00051-t002){ref-type="table"}).

Antioxidants are believed to be directly antimutagenic \[[@B43-medicines-04-00051]\] and anticarcinogenic due to their radical scavenging properties \[[@B44-medicines-04-00051],[@B45-medicines-04-00051]\]. The oil of *E. egensis* showed significant antioxidant activity, but no cytotoxicity against cancer cell lines (*IC*~50~ \> 25.0 µg/mL). These results should be attributed to the presence of the phenolic ring in the structure of 5-hydroxy-*cis*-calamenene, as many phenolic compounds are reported as cytoprotectives \[[@B46-medicines-04-00051]\].

4. Conclusions {#sec4-medicines-04-00051}
==============

Our investigation of the chemical profile of the *Eugenia* essential oils has contributed to chemosystematic studies of Myrtaceae species, for which the occurrence of bisabolane-type skeletons and acyclic sesquiterpenes as important characteristics have been reported. Additionally, it is the first report for the presence of 5-hydroxy-*cis*-calamenene in *Eugenia* oils. The essential oils showed significant antioxidant activity and selective cytotoxicity against HCT-116 cancer cells (colon) and did not promote membrane damage. The results suggest that *Eugenia* oils could be tested in future studies for the treatment of colon cancer and oxidative stress management.
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The following abbreviations are used in this manuscript.

DMSO

dimethylsulfoxide

DPPH

2,2-diphenyl-1-picrylhydrazyl

GC-MS

gas chromatography/mass spectrometry

GC-FID

gas chromatography/flame ionization detector

MTT

3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide

TEAC

trolox equivalent antioxidant capacity

Triton X-100

nonionic surfactant, octylphenol ethoxylate

![Antioxidant activity of the *Eugenia* oils by the DPPH assay. Results expressed in milligrams of Trolox (**A**) and BHA (**B**) equivalent per milliliter of sample. Mean ± standard deviation (*n* = 3). Values with different letters in the figure represents statistical differences at the *p* \< 0.05 level (Tukey's test).](medicines-04-00051-g001){#medicines-04-00051-f001}
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###### 

Composition (%) of the oils of *Eugenia* species.

  Constituents                           RI~Calc.~   RI~Lit.~   *Eugenia egensis*   *Eugenia flavescens*   *Eugenia patrisii*   *Eugenia polystachya*
  -------------------------------------- ----------- ---------- ------------------- ---------------------- -------------------- -----------------------
  Limonene                               1026        1024                                                                       0.1
  α-Terpineol                            1187        1186                                                  0.1                  
  Thymol                                 1290        1289                                                  0.1                  
  δ-Elemene                              1337        1335       1.6                 0.5                    0.3                  4.1
  α-Cubebene                             1348        1345       2.2                                                             0.1
  α-Ylangene                             1374        1373       0.1                                                             0.1
  α-Copaene                              1376        1374       1.6                                        0.1                  0.6
  β-Bourbonene                           1388        1387       0.2                                                             0.3
  β-Elemene                              1390        1389       2.5                 0.2                    0.1                  2.2
  7-*epi*-Sesquithujene                  1392        1390                           0.1                                         
  Sesquithujene                          1407        1405                           0.1                                         
  α-Gurjunene                            1410        1409       1.5                                                             
  (*Z*)-α-Bergamotene                    1412        1411                           0.2                                         
  β-Caryophyllene                        1418        1417       8.9                 2.8                    0.9                  2.3
  β-Ylangene                             1420        1419                                                                       5.0
  β-Gurjunene                            1432        1431       0.7                 0.2                    0.1                  3.5
  (*E*)-α-Bergamotene                    1433        1432                           0.4                                         
  α-Guaiene                              1439        1437       0.1                                                             0.2
  Aromadendrene                          1440        1439       0.1                                        0.1                  
  (*Z)*-β-Farnesene                      1442        1440                           0.4                                         
  6,9-Guaiadiene                         1444        1442                                                                       1.2
  (*E*)-Muurola-3,5-diene                1454        1451       5.9                                                             
  α-Humulene                             1455        1452       2.0                                        0.4                  1.3
  Geranyl acetone                        1456        1453                                                  0.6                  
  (*E*)-β-Farnesene                      1457        1454                           4.7                                         
  β-Santalene                            1460        1457                           0.1                                         
  *allo*-Aromadendrene                   1462        1458       0.9                                        0.2                  
  (*Z*)-Cadina-1(6),4-diene              1464        1461       0.1                                                             0.6
  Ishwarane                              1467        1465                                                                       15.7
  β-Acoradiene                           1470        1469                           0.2                                         
  Dauca-5,8-diene                        1473        1471                           1.2                                         
  (*E*)-Cadina-1(6),4-diene              1476        1475       1.6                                                             
  γ-Gurjunene                            1477        1475                                                                       0.7
  γ-Muurolene                            1480        1478       0.3                                        0.1                  1.0
  Germacrene D                           1486        1484       2.2                                        0.8                  18.4
  Aristolochene                          1488        1487                                                                       2.1
  β-Selinene                             1490        1489       0.4                                        0.1                  0.9
  (*Z*)-β-Guaiene                        1494        1492       3.8                                                             1.4
  α-Zingiberene                          1496        1493                           1.6                                         
  Viridiflorene                          1497        1496                                                  0.3                  
  Bicyclogermacrene                      1501        1500       1.2                                        0.5                  5.1
  α-Muurolene                            1502        1500       0.5                                        0.2                  1.7
  β-Bisabolene                           1506        1505                           34.7                   0.3                  
  (*Z*)-α-Bisabolene                     1508        1506                           0.4                                         
  δ-Amorphene                            1512        1511                           0.3                                         
  γ-Cadinene                             1515        1513       0.2                                        0.1                  0.8
  Cubebol                                1516        1514       0.1                                        0.1                  0.5
  7-*epi*-α-Selinene                     1521        1520                                                                       7.5
  β-Sesquiphellandrene                   1523        1521                           3.4                    0.1                  
  (*E*)-Calamenene                       1523        1521       6.1                                        0.1                  0.3
  δ-Cadinene                             1524        1522       2.3                                        0.6                  
  (*E*)-*iso*-γ-Bisabolene               1530        1529                           5.1                                         
  (*E*)-γ-Bisabolene                     1531        1530                           35.0                                        
  (*E*)-Cadina-1,4-diene                 1534        1533       6.3                                                             0.2
  10-*epi*-Cubebol                       1535        1533                                                                       0.1
  α-Cadinene                             1539        1537                                                  0.1                  0.2
  α-Calacorene                           1546        1544                                                                       0.3
  Elemol                                 1549        1548       0.1                                                             0.7
  1-*nor*-Bourbonanone                   1562        1561                                                                       0.1
  (*E*)-Nerolidol                        1563        1561                                                  0.2                  
  β-Calacorene                           1566        1564                                                                       0.2
  Palustrol                              1568        1567       0.3                                        0.3                  0.2
  Spathulenol                            1578        1577       0.3                 0.1                    4.4                  3.0
  Caryophyllene oxide                    1582        1582       0.1                 0.2                                         0.8
  Globulol                               1591        1590       0.7                 0.2                                         0.7
  Viridiflorol                           1592        1592       0.2                 0.1                    0.7                  0.3
  Cubeban-11-ol                          1596        1595       0.2                                                             
  Rosifoliol                             1601        1600                           0.2                    2.0                  
  Guaiol                                 1602        1600                           0.8                    0.1                  
  Ledol                                  1603        1602       5.0                                        0.3                  0.3
  Humulene epoxide II                    1609        1608                                                  0.2                  0.6
  Junenol                                1620        1618                                                                       0.4
  β-Cedrene epoxide                      1621        1620                                                                       0.4
  α-Corocalene                           1623        1622                                                                       0.3
  1-*epi*-Cubenol                        1629        1627       0.7                                                             0.5
  α-Acorenol                             1633        1632                           0.1                                         
  Gossonorol                             1638        1636                           0.3                                         
  *epi*-α-Cadinol                        1639        1638       0.6                 0.3                                         0.8
  Caryophylla-4(12),8(13)-dien-5α-ol                                                                                            
  and                                                                                                                           
  Caryophylla-4(12)-8(13)-dien-5β-ol     1640        1639       15.6                                                            
  *epi*-α-Murrolol                       1643        1640       0.5                 0.2                                         0.8
  α-Muurolol                             1645        1644       0.3                                                             0.8
  α-Cadinol                              1654        1652       0.8                 0.3                    2.5                  3.3
  Selin-11-en-4-α-ol                     1661        1658       0.2                                                             0.8
  *epi*-β-Bisabolol                      1670        1670                           0.4                                         
  Bulnesol                               1672        1670                                                  0.7                  
  Cadalene                               1676        1675                                                                       0.3
  *epi*-α-Bisabolol                      1684        1683                           0.2                                         
  Germacra-4(15),5,10(14)-trien-1-α-ol   1685        1685                           0.1                                         0.6
  α-Bisabolol                            1686        1685                           1.0                                         
  Eudesma-4(15),7-dien-1-β-ol            1687        1687                                                                       0.3
  2,3-dihydro-Farnesol                   1688        1688                                                  1.3                  
  *cis*-Thujopsenal                      1708        1708                           0.1                                         
  (2*E*,6*Z*)-Farnesal                   1714        1713                           0.1                                         
  5-hydroxy-(*Z*)-Calamenene             1715        1713       35.8                                                            
  (2*E*,6*Z*)-Farnesol                   1716        1714                                                  23.2                 
  (2*E*,6*E*)-Farnesal                   1742        1740                                                  1.8                  
  (2*E*,6*E*)-Farnesol                   1744        1742                                                  34.5                 
  (2*E*,6*E*)-Methyl farnesoate          1784        1783                                                  0.7                  
  (2*Z*,6*E*)-Farnesyl acetate           1821        1821                                                  0.3                  
  Monoterpene hydrocarbons                                                          0.1                                         
  Oxygenated monoterpenes                                       0.2                                                             
  Sesquiterpenes hydrocarbons            53.3        91.6       6.3                 77.9                                        
  Oxygenated sesquiterpenes              45.9        4.7        88.9                16.4                                        
  Total                                  99.2        96.3       95.4                94.4                                        

RI~Calc.~ = based on DB-5ms capillary column and alkane standards (C~8~-C~32~) according Van den Dool and Kratz (1963). RI~Lit.~ = based on Adams (2007).

medicines-04-00051-t002_Table 2

###### 

Cytotoxic activity of the *Eugenia* oils on cell lines, after 72 h exposure.

  *Eugenia* Species   *IC*~50~ (µg/mL) \*     Hemolysis                                                                    
  ------------------- ----------------------- --------------------------- ------------------------ ----------------------- -----------
  *E. egensis*        \> 25                   \> 25                       \> 25                    ND                      \> 200
  *E. flavescens*     \> 25                   13.9 ^a^ (12.0--15.9)       \> 25                    14.0 ^a^ (10.4--18.6)   \> 200
  *E. patrisii*       \> 25                   16.4 ^b^ (14.6--18.3)       \> 25                    18.1 ^b^ (13.9--23.4)   \> 200
  *E. polystachya*    \> 25                   10.3 ^c^ (8.3--12.8)        \> 25                    \>25                    \> 200
  Doxorubicin         0.254 µM (0.19--0.33)   0.10 µM ^d^ (0.047--0.28)   0.045 µM (0.013--0.15)   0.20 µM (0.16--0.25)    \>2 00 µM
                      HCT-15/HT-29            Sbc-12/WM3211                                                                
  Eugenol                                     500.0 µM/300 µM             0.5 µM                                           

\* Data are presented as *IC*~50~ values and 95% confidence intervals obtained by nonlinear regression for all cell lines, from three independent experiments. Doxorubicin and eugenol \[[@B41-medicines-04-00051],[@B42-medicines-04-00051]\] were used as positive controls. Only compounds with *IC*~50~ values lower than 25 µg/mL, in at least one cell line, were considered active. ND = not determined. Values with different letters are statistically different at the *p* \< 0.05 level (Tukey's test).
